Antonetti Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $17.7K | Hold |
390
| – | – | 0.03% | 169 |
|
|
2023
Q2 | $21.9K | Hold |
390
| – | – | 0.03% | 155 |
|
|
2023
Q1 | $17.6K | Hold |
390
| – | – | 0.03% | 179 |
|
|
2022
Q4 | $15.9K | Hold |
390
| – | – | 0.02% | 192 |
|
|
2022
Q3 | $25K | Sell |
390
-1,250
| -76% | -$80.1K | 0.03% | 142 |
|
|
2022
Q2 | $100K | Buy |
1,640
+450
| +38% | +$27.4K | 0.11% | 68 |
|
|
2022
Q1 | $75K | Hold |
1,190
| – | – | 0.07% | 90 |
|
|
2021
Q4 | $90K | Buy |
1,190
+165
| +16% | +$12.5K | 0.07% | 122 |
|
|
2021
Q3 | $115K | Buy |
+1,025
| New | +$115K | 0.09% | 111 |
|